Related Experiment Video
Updated: Mar 11, 2026
05:53
Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
17.2K
Frailty and multimorbidity: Two related yet different concepts
Patricia Villacampa-Fernández1, Esperanza Navarro-Pardo1, Juan J Tarín2
1Department of Developmental and Educational Psychology, University of Valencia, Spain.
Maturitas
|November 28, 2016
Summary
As people live longer, frailty and multimorbidity increase, impacting health outcomes. Though related, frailty signifies vulnerability from depleted reserves, while multimorbidity is having multiple chronic diseases.
Area of Science:
- Gerontology
- Public Health
- Clinical Medicine
Background:
- Global life expectancy extension presents challenges with an aging population.
- Increased prevalence of frailty and multimorbidity in older adults is a significant health concern.
- Both frailty and multimorbidity are strongly linked to adverse outcomes like disability, hospitalization, and mortality.
Purpose of the Study:
- To conceptualize and differentiate between frailty and multimorbidity.
- To discuss the interrelations between these two distinct clinical conditions.
- To clarify the definitions of frailty and multimorbidity in the context of aging populations.
Main Methods:
- Conceptual analysis of existing literature on frailty and multimorbidity.
- Comparative analysis to distinguish the defining characteristics of each condition.
- Discussion of the clinical implications and interconnections.
Main Results:
- Frailty is defined as increased vulnerability to stressors due to depletion of physiological reserve.
- Multimorbidity is characterized by the coexistence of two or more clinically manifest chronic diseases.
- Frailty and multimorbidity are related but represent distinct clinical entities.
Conclusions:
- Frailty and multimorbidity are distinct conditions despite their association.
- Understanding the differences is crucial for accurate diagnosis and management in aging populations.
- Further research can explore the dynamic interplay and management strategies for both conditions.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
339
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
339
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
307
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
307
01:18Factors Affecting Illness
5.6K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
5.6K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
291
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
291
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
307
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
307
01:19The Effect of Aging on Tissues
4.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.1K